论文部分内容阅读
目的 观察肝复肽 (促肝细胞生长素 )治疗慢性乙型肝炎的临床疗效。方法 采用肝复肽注射液治疗慢性乙型肝炎患者 30例 ,36例作为对照组。治疗 1个月和 2个月时 ,分别观察临床症状、体征及肝功能 (包括ALT和TB)的变化。结果 ALT、TB在治疗 1个月或 2个月后 ,恢复程度以治疗组为高 ,与对照组比较有统计学差异 (P <0 0 5 )。采用肝复肽治疗 8w后 ,总有效率为 96 6 % ,比对照组高。结论 肝复肽在慢性乙型肝炎的治疗中有较满意的疗效。
Objective To observe the clinical efficacy of hepatic multiple peptide (hepatocyte growth-promoting factor) in the treatment of chronic hepatitis B Methods 30 patients with chronic hepatitis B were treated with hepatic peptide injection and 36 as control group. At 1 and 2 months of treatment, changes in clinical symptoms, signs, and liver function (including ALT and TB) were observed. Results After treatment for 1 month or 2 months, the recovery of ALT and TB was higher in the treatment group than in the control group (P <0.05). After heparin treatment of 8w, the total effective rate was 96 6%, higher than the control group. Conclusion hepatic peptide in the treatment of chronic hepatitis B have more satisfactory results.